About Us

The BP Clinic is a place that is rarely seen in our country and serves with the motto of “personal health, personalized oncology” with physicians and specialists from mixed disciplines. Contrary to the health system that is used to treating, it also helps people not to get sick.

Professor Doctor Berrin Pehlivan Radiation Oncologist graduated from Hacettepe University in 2000 and continued her studies in France and Switzerland for 4.5 years after receiving her expertise from the same university. After returning home, she did his MBA. She is still a faculty member at Bahcesehir University. She speaks English and French, wrote the book Cancer in 50 Questions, and also writes a column for Milliyet Newspaper under the name of Bilim Günlügü.

Pehlivan says that PB Clinic is like a “thank you” to his readers on Milliyet Cadde. She says that For a long time, in every channel I was called, in my book and articles – Cancer in 50 Questions- I insistently repeated; Please make health a habit, due to the fact that it has processes as crucial as the treatment of cancer and other chronic diseases. There is a before, diagnosis, treatment and after all.

Please act accordingly to opinions of my colleagues from all disciplines. Fight with this disease with a team, do not sacrifice your post-treatment comfort with panic… They did not ask me for an address, “what are you doing about it?” they didn’t say. But I had to say that at least finally, I did my part and opened this clinic.

Staying Healthy in Today is Now Individual!

The desire to live healthy before the pandemic was like a fashion. However, with the pandemic, it became a necessity. Today, we know that few diseases are hereditary. Therefore, our choices are the cause of many diseases, especially cancer.

The other thing we know is that we can improve our health by acting according to our differences, not on gossip. That we should choose our lifestyle, our style, what we eat, what we drink, and everything we experience according to our genes, not this or that. There is no treatment, no approach or no medicine that will be perfect for all of us!

Services

We determine who will be given what treatment, by doing personal genetic tests. Our council team evaluates the results of genetic testing that has been completed.

It is possible for BP Clinic to apply the latest technology in radiotherapy. BP Clinic successfully uses IMRT, Ark and radiosurgery solutions. In addition, we can apply all kinds of supportive treatment these includes;

  1. Hyperthermia
  2. Ozone Therapy
  3. High-Dose Vitamin C

These will increase the effectiveness of treatments such as radiotherapy, immunotherapy, etc.

Our team, which aims to address not only the disease but also habits, anxieties, nutrition, and mental state as a whole. Consisting of physicians and health experts in the fields of psychology, physiotherapy oncology, diet and finally nutrition.

Our only focus is not curing the disease. BP Clinic’s argument “there has to be one or more wrong or missing things you did that caused to cancer”. Due to the fact that a small percentage of cancers are hereditary. After treating you in the best way, they aim to find these mistakes and rearrange your life in order to minimize the risk of recurrence of the disease.

Of course, we also do this individually. With an active process that you will be involved; not with the types that stereotypical and standard recommendations applied to everyone. Tailored only for you and according to your needs… We determine the most suitable lifestyle and diet for you with your genetic tests.

In our clinic Cancer check-ups, health life prescriptions under the guidance of genetic tests, ozone therapy and antioxidant treatments are professionally applied. There are also Psychologist, Psychiatrist, Physiotherapist, Metabolism Specialist, Dietitian and Endocrine in BP Clinic’s professional. For cancer patients, the consultant Medical Oncologist and surgeons of the relevant department can give detailed consultancy.

We offer our patients a large number of intravenous treatment options for different healing effects. To achieve desired effect sometimes a single compound or sometimes combination treatments can be used. Which protocol we will apply depends on the client’s complaints, health characteristics or expectations. Some protocols we apply are as follows;

  1. Anti-Aging
  2. Chronic Fatigue
  3. Immunity
  4. Athlete Health
  5. High Dose Vitamin C
  6. Antioxidant Treatments
  7. Brain and Nervous System Health
  8. Migraine
  9. Hangover (After Alcohol)
  10. Supportive Treatments After Cancer Treatment

The reason behind I wrote this book is to put an and to seeing cancer as an otherworldly scourge from a mystical world above all human diseases! Revealing it in all its nakedness, simplicity, and misery in front of human will and intellect… To see cancer as a preventable and defeatable disease…

However, despite everything, the most crucial reason behind why we are still succumbing to this disease is our cancer-causing habits. Our unquestioned desperation that we feel as soon as we hear its name is also a factor. When we have the will to ask the right questions and integrate the right answers into our lives, life will turn into a river that flows within us, not into which we flow.

Prof. Dr. Berrin Pehlivan’s Scientific Studies

A. Articles published in international peer-reviewed journals:

  1. Yilmaz B, Somay E, Topkan E, Pehlivan B, Selek U. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients. Eur Arch Otorhinolaryngol. 2023 Feb 7.
  2. Somay E, Yilmaz B, Topkan E, Kucuk A, Pehlivan B, Selek U. Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer. Oral Dis.2022 Nov 8.
  3. Somay E, Yilmaz B, Topkan E, Kucuk A, Haksoyler V, Pehlivan B, Selek U, Araz K. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy. Oral Dis 2022 Aug 29.
  4. Topkan E, Selek U, Kucuk A, Pehlivan Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas. J Inflamm Res. 2022 Sep 18;15:5413-5423.
  5. Topkan E, Selek U, Haksoyler V, Kucuk A, Durankus NK, Sezen D, Bolukbasi Y, Pehlivan B. Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers. Int J Clin Pract. 2022 Jan 31;2022:7473649.
  6. Yalcin K, Pehlivan B, Celen S, Bas EG, Kabakci C, Pashayev D, Daloglu H, Zhumatayev S, Uygun V, Karasu GT, Hazar V, Yesilipek A. Comparison of Total Body Irradiation-based Versus Chemotherapy-based Conditionings for Early Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Children With ALL. J Pediatr Hematol Oncol2021 Mar 31.
  7. Kucuk A, Topkan E, Selek U, Haksoyler V, Mertsoylu H, Besen AA, Pehlivan B. High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients. Ther Clin Risk Manag. 2022 Apr 14;18:421-428.
  8. Topkan E, Selek U, Küçük A, Haksöyler V, Özdemir Y, Sezen D, Mertsoylu H, Besen AA, Bölükbaşı Y, Özyılkan O, Pehlivan B. Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis. J Oncol 2021 Jan 23;2021.
  9. Küçük A, Ozkan EE, Öztep SE, Mertsoyle H, Pehlivan B, Selek U, Topkan E. The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. J Oncol 2020 Dec 16.
  10. Topkan E, Besen AA, Mertsoylu H, Kucuk A, Pehlivan B, Selek U. Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide. Int J Inflam. 2020 Jun 8;2020.
  11. Topkan E, Mertsoylu H, Kucuk A, Besen AA, Sezer A, Sezen D, Bolukbasi Y, Selek U, Pehlivan B. Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy. Gastroenterol Res Pract. 2020 Jul 30;2020.
  12. Topkan E, Ozdemir Y, Guler OC, Kucuk A, Besen AA, Mertsoylu H, Sezen D, Akdemir EY, Sezer A, Bolukbasi Y, Pehlivan B, Selek U.  Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study. J Oncol. 2020 Sep 4;2020.
  13. Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi Y, Pehlivan B, Selek U. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol. J Immunol Res. 2020 Nov 14;2020.
  14. Kucuk A, Ozkan EE, Eskici Oztep S, Mertsoylu H, Pehlivan B, Selek U, Topkan E. The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. J Oncol2020 Dec 16;2020.
  15. Topkan E, Besen AA, Ozdemir Y, Kucuk A, Mertsoylu H, Pehlivan B and Selek U. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Post-neurosurgical Radiotherapy plus Concurrent and Adjuvant Temozolomide. Mediators Inflamm. 2020 23;2020.
  16. Kucuk A, Topkan E, İkiz ED, Durankuş N, Senyurek S, Aydemir EY, Sezen D, Bolukbaşı Y, Selek U, Pehlivan B. Combination of stereotactic radiosurgery with immunotherapy: is it a new treatemnt option for brain metastases? Int Res J Oncol, 2020.
  17. Topkan E, Küçük A, Şenyürek S, Sezen D, Durankuş NK, Aydemir EY, İkiz ED, Bölükbaşı Y, Pehlivan B ve Selek U. Preoperative radiosurgery in management of brain metastases. J Cancer Tumor Int, 10(1):1-11, 2020.
  18. Topkan E, Küçük A, Sezen D, Senyürek S, Aydemir EY, Durankuş N, İkiz ED, Bolükbaşı Y, Pehlivan B ve Selek U. Common prognostic scoring system for patients presenting with brain metastases. Clin Oncol Res, 2020.
  19. Pehlivan B, Topkan E, Küçük A, Okumuş A, Sezen D, Bölükbaşı Y, Selek U. Stereotactic radiosurgery and targeted therapies for brain metastases from solid cancers. JAMMR,ISSN:2456-8899.
  20. Topkan E, Küçük A, Durankuş NK, Şenyürek Ş, Akdemir EY, Sezen D, İkiz ED, Bölükbaşı Y, Pehlivan B, Selek U. Radiosurgical management of brainstem metastasis. Int Res J Oncol, 2020 3(1):37-46.
  21. Sağlam Y, Bölükbaşı Y, Atasoy Aİ, Karaköse F, Alpan V, Selek U, Küçük A, Pehlivan B, Topkan E. Quality assurance in stereotactic radiosurgery and stereotactic body radiotherapy. Advances in Research 21 (7), 22-33.
  22. Topkan E, Küçük A, Şenyürek Ş, Sezen D, Durankuş NK, Akdemir EY, Sağlam Y, Bölükbaşı Y, Pehlivan B, Selek U. Radiosurgery techniques for brain metastases. JCTI 2020; 10, 1-14.
  23. Bölükbaşı Y, Selek U, Sezen D, Durankuş NK, Akdemir EY, Şenyürek Ş, Küçük A, Pehlivan B, Topkan E. Tumor cavity stereotactic radiosurgery for resected brain metastases. JCTI 2020, 10(2):15-30.
  24. Pehlivan B, Sengul K, Yesil A, Nalbant N, Ozturk O, Ozdemir Y, Topkan E. Dosimetric comparison of lung-sparing radiation therapy between volumetric arc therapy and helical tomotherapy for unresectable malignant pleural mesothelioma. BioMed Res Int, 2019.
  25. Pehlivan B, Kucuk A, Mertsoylu H, Topkan E. Current management of brainstem gliomas. Int. J.Adv. Res. 7(9), 2019.
  26. Topkan E, Pehlivan B. Radiation-induced abscopal effects on cardiovascular system. IndJMedResPharmSci, 6(9), 2019.
  27. Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A, Hartley A, Mehanna H. Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol. 2019 Jan;88:145-152.
  28. Topkan E, Selek U, Ozdemir Y, Besen AA, Guler OC, Yildirim BA, Mertsoylu H, Findikcioğlu A, Ozyılkan O, Pehlivan B. Risk factors for .fatal pulmonary hemorrahage following concurrent chemoradiotherapy in stage 3B/C squamous-cell lung carcinoma patients. J Oncol 2018 Nov 1;2018.
  29. Topkan E, Yildirim BA, Guler OC, Parlak C, Pehlivan B, Selek U. Safety and palliative efficacy of single-dose-8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):774-80.
  30. Duman E, Cecen Y, Sındır B, Ozdemir B, Yıldırım M, Cecen S, Pehlivan B, Yavuz MN. Dosimetric evaluation of Adaptive Therapy in non-small lung cancer patients undergoing palliative thoracic Radiotherapy. Int J Hematol Oncol. 2015, 25:178-185.
  31. Mirimanoff RO, Ozsahin M, Thariat J, Ozyar E, Schick, Pehlivan B, Krengli M, Pellanda AF, Vess H. Cai L, Scandolaro L, Belacemi Y, Villa S, Igdem S, Lutsyk M, Miller RC. History of rare cancer network and past research. Rare Tumors. 2014 Aug 6;6(3):5462.
  32. Sarıca FB, Cekinmez M, Tufan K, Sen O, Onal HC, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Altinors B. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and efeectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012 Oct;7(4):181-90.
  33. Topkan E. Parlak C, Topuk S, Pehlivan B. Influence on oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. BMC Cancer 2012 Oct 31;12:502.
  34. Pehlivan B, Ares C, Lomax T, Stadelmann O, Goitein G, Timmermann B, Schneider RA, Hug EB.: Temporal lobe toxicity analyasis after proton radiation therapy for skull base tumors. Int J Radiat Oncol Biol Phys 2012 Aug 1;83(5):1432-40.
  35. Topkan E, Parlak C, Kotek A, Yuksel O, Cengiz M, Ozsahin M, Pehlivan B. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens. Int J Radiat Oncol Biol Phys 2012 July 15;83(4):1264-71.
  36. Pehlivan B, Onal C, Yavuz M.: Retinoblastoma Tedavisinde Eksternal Radyoterapinin Rolü ve Radyoterapi Seçenekleri. Int J. Hematol Oncol. 2012, 22(2):1-9.
  37. Topkan E, Parlak C, Kotek A, Yapar AF, Pehlivan B. Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy. BMC Gastroenterol 2011 10,11:123.
  38. Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Am J Clin Oncol 2012; 35(3):284-9.
  39. Sarıca F, Tufan K, Çekinmez M, Şen O, Onal HC, Mertsoylu H, Pehlivan B, Erdoğan B, Altınors MN. Effectiveness of temozolomide treatment used at thesame time with radiotherapyand adjuvant temozolomid: concomitant therapy of glioblastoma multiforme:         multivariate analysis and other prognostic factors. J Neurosurg Sci. 2010; 54(1): 7-19.
  40. Ozsahin M, Gruber G, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M, Kaanders JH, Cengiz M, Krengli M, Matzinger O, Zouhair A.: Outcome and prognostıc factors ın olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):992-7.
  41. Yavuz MN, Topkan E, Yavuz AA, Aydin M, Onal C, Reyhan M, Kotek A, Pehlivan B, Yapar AF.: FDG-PET/CT Imaging-based taget volume delineation for preoperative conformal radiotherapy for rectal carcinoma. Int J Hematol Oncol 2010, 20(2):067-074.
  42. Pehlivan B, Topkan E, Onal C, Nursal GN, Yüksel O, Yavuz M, Yavuz A.: Comparison of CT and integrated PET-CT based radiation therapy planning in malign plevral mesothelioma patients. Radiat Oncol. 2009, 4:35.
  43. Pehlivan B, Luthi F, Matzinger O, Betz M, Dragusanu D, Bulling S, Bron L, Pasche P, Seelentag W, Mirimanoff RO, Zouhair A, Ozsahin M.: Feasibility and efficacity of accelerated weekly concomitant boost postopeartive radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer. Ann Surg Oncol. 2009, 16:1337-1343.
  44. Pehlivan B, Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients. Acta Oncol. 2009, 48(3):440-5.
  45. Pehlivan B, Zouhair A, Luthi F, Bron L, Pasche P, Dragusanu D, Azria D, Matzinger O, Mirimanoff RO, Ozsahin M.: Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy. Ann Surg Oncol. 2009, 16:1331-1336.
  46. Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz A.: Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009 Jul 1;28:95.
  47. Onal C, Pehlivan B, Bal N, Topkan E, Kilinc F, Topuk S. : Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report. Clinical Medicine: Case Reports 2009:2 39-42.
  48. Onal C, Yuksel O, Topkan E, Pehlivan B. : Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: case report. Cases Journal 2009, 2:8402.
  49. Atahan IL, Yıldız F, Ozyar E, Pehlivan B, Genç M, Köse M, Tulunay G, Ayhan A, Yuce K, Güler N, Kucukali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors. Int J Gynecol Cancer 2007, 17 (4): 813-820.
  50. Garcia R, Bourhis J, Pehlivan B, Pichenot C, Alfonsi M.: Intensity modulated radiotherapy for cancers of the upper aerodigestive tract. Cancer Radiother 2007, 11(6-7):353-7.
  51. Pehlivan B, Topkan E, Yavuz A.: Protonterapy in clinical use. Ege Tıp Dergisi, 50(1):1-6, 2011

B. Proceedings presented at international scientific meetings and published in the proceedings book:

B1. Pehlivan B,Zouhair A, Luthi F, Bron l, Pasche P, Seelentag W, Mirimanoff RO, Ozsahin M.: Accelerated weekly concomitant boost postoperative radiation therapy combined to concomitant chemotherapy in patients with locally advanced head and neck cancer. Scientific Association of  Swiss Radiation Oncology (SASRO), Mart 2007, Aarau, İsviçre.

B2. Pehlivan B, Ozsahin M, Bron L, Pasche P, HP Do, Luthi F,  Mirimanoff RO, Pica A.: High-dose rate brachytherapy in the treatment of recurrent head and neck cancer. Scientific Association of Swiss Radiation Oncology (SASRO), Mart 2007, Aarau, İsviçre.

B3. Pehlivan B, Ares C, Stadelmann O, Lomax T, Hug EB.: Temporal lobe toxicity analysis following spot scanning proton radiation therapy for skull base tumors. Internatinal Translational Research Congress in Radiation Oncology, Mart 2009, Cenevre, İsviçre.

B4. Ozsahin M, Olszyk O, Karakoyun-Celik O, Pehlivan B, Azria D, Roelandts M,  Kaanders JH, Cengiz M, Krengli M, Zouhair A.: Outcome and prognostic factors in olfactory neuroblastoma: a multicenter rare cancer network study. American Society of Therapeutic Radiation Oncology (ASTRO), Ekim 2005, Denver, ABD.

B5. Zouhair A, Dragusanu D, Matzinger O, Pehlivan B, Khanfir K, Ris HB, Stupp R, Moeckli RO, Ozsahin M.: Postoperative 3D conformal radiation therapy with dose-volume histogram assesment in non small-cell lung cancer. American Society of Therapeutic Radiation Oncology (ASTRO), Ekim 2007, Los Angeles, ABD.

B6. Dhermain F, Ducreux D, Bidault F, Parker F, Pehlivan B, Beaudre A, Haie-Meder C, Bourhis J.: Radiotherapy planning for WHO grade 2 and grade 3 supra-tentorial gliomas: first experience with 10 consecutive patients. The European Cancer Conference (ECCO) 13, Ekim 2005, Paris, Fransa.

B7. Atahan L, Yıldız F, Ozyar E, Pehlivan B, Köse F, Tulunay G, Ayhan A, Yüce K, Güler N, Küçükali T.: Radiotherapy in the adjuvant setting of cervical carcinoma: Treatments results and prognostic factors. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Ekim 2006, Leipzig, Almanya.

B8. Pehlivan B,Pichenot C, Casting M, Auperin A, Arriagada R, Bourhis J.: Verification of patient position by daily electronic portal imaging in head and neck cancer traeted with IMRT. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Ekim 2006, Leipzig, Almanya.

B9. Pehlivan B, Rutz HP, Goiten G, Haller K, Lomax A, Hug E, Timmermann B.: Case Report: Proton radiation therapy for secondary atypical lumbar meningioma arising 25 years after interdisciplinary treatment for advanced wilms tumor. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Eylül 2008, Göteborg, İsveç.

B10. Pehlivan B, Kotek A, Akkaneren S, Topkan E. Outcome of profilactic cranial irradiation in 112 patients with recursive partitioning analysis group I locally advanced (Stage IIIB) non-small cell lung carcinoma. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Eylül 2010, Barselona, İspanya.

B11. Pehlivan B, Yuksel O, Akkaneren Ş, Topkan E.Pseudoprogression in patients with glioblastome multiforme following concurrent radiotherapy and temozolomide. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Eylül 2010, Barselona, İspanya.

B12. Pehlivan B, Akkaneren Ş, Kotek A, Topkan E. Survival outcome in unresectable locally advanced pancreatic carcinoma patients treated with coregistered PET-CT based radiation therapy planning without elective nodal irradiation. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Eylül 2010, Barselona, İspanya.

B13. Pehlivan B, Oymak E, Kotek A, Akkaneren S, Topkan E. Oral glutamine supplementation for amelioration of acute radiation induced esophagitis has no negative impact on survival outcome in locally advanced non-small cell lung cancer treated with thoracic irradiation. European Society of Therapeutic Radiation Oncology (ESTRO) Annual Meeting, Eylül 2010, Barselona, İspanya.

B14. Pehlivan B, Kotek A, Akkaneren S, Topkan E: Comparison of CT and PET/CT based radiotherapy planning in hepatic metastases from colorectal and breast primaries. 5th International Asian Pacific Organization for Cancer Prevention Conference, Nisan 2010, İstanbul

B15. Parlak C, Pehlivan B, Oymak E, Topuk S, Topkan E. Prognostic Importance of Gross Tumor Volume Defined by Utilizing 18-FDG-PET/CT in Stage IIIB Non-small Cell Lung Carcinoma Treated with Definitive Chemoradiotherapy. European Multidisciplinary Conference on Thoracic Oncology 2010 Abstract Book. Lung Cancer 71 suppl. 2: 2011

B16. Topkan E, Yuksel E, Kotek A, Parlak C, Pehlivan B. Oral glutamine supplementation has no negative impact on survival in locally advanced non-small cell lung cancer treated with coccurrent chemotherapy. European Multidisciplinary Conference on Thoracic Oncology 2010 Abstract Book. Lung Cancer 71 suppl. 2: 2011

B17. Pehlivan B, Kotek A, Yuksel O, Topkan E. Impact of Chemotehrapy Sequence on Brain Relaps Rates in Patients with Stage IIIB Non-small Cell Lung Carcinoma Treated with Concurrent Chemoradiotherapy Plus Prophylactic Crainial Irradiation. European Multidisciplinary Conference on Thoracic Oncology 2010 Abstract Book. Lung Cancer 71 suppl. 2: 2011

B18. Topkan E, Parlak C, Guler OC, Pehlivan B, Selek U. Impact Of Pretreatment Leukocytosis On Prognosis In Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy. 15th World Conference on Lung Cancer, Sydney, Australia. J Thorac Oncol 8 (Supplement 2)

B19. Topkan E, Parlak C, Pehlivan B, Ozyilkan O, Selek U. Efficacy Of Single Dose 8-Gy Palliative Chest Irradiation In Pain Palliation Of Patients With Locoregionally Recurrent Stage IV Non-small Cell Lung Cancer. 15th World Conference on Lung Cancer, Sydney, Australia. J Thorac Oncol 8 (Supplement 2)

B.20. Topkan E, Parlak C, Guler OC, Pehlivan B, Ozyilkan O, Selek U. Impact Of Change In Hemoglobin Levels During Treatment On Prognosis In Non-anemic Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy. 15th World Conference on Lung Cancer, Sydney, Australia. J Thorac Oncol 8 (Supplement 2):

B21. Topkan E, Parlak C, Pehlivan B, Selek U, Ozyilkan O. Prognosis Of Stage III Non-Small Cell Lung Cancer Patients Initially Presenting With Superior Vena Cava Syndrome Treated With Partially Accelerated Definitive Concurrent Chemoradiotherapy. 15th World Conference on Lung Cancer, Sydney, Australia. J Thorac Oncol 8 (Supplement 2): s1149: 2013.

B22. Topkan E, Parlak C, Pehlivan B, Ozyilkan O, Selek U. Long Treatment Duration Is Associated With Poor Prognosis In Patients Receiving Concurrent Chemoradiotherapy With The Diagnosis Of Stage IIIB Non-Small Cell Lung Cancer. 15th World Conference on Lung Cancer, Sydney, Australia. J Thorac Oncol 8 (Supplement 2)

B23. Yeşil A, Topkan E, Özcan D, Taşçı N, Yilmaz F, Meral Ö, Pehlivan B. Hippocampi and Scalp Sparing Whole Brain Radiotherapy and Simultaneous Integrated Boost in Patients Presenting with Multiple Brain Metastases. Accuray User Meeting, Nisan 2016, San Francisco, USA

B24. Yeşil A, Özcan D, Taşçı N, Bayazıt B,Pehlivan B. Comparison of Adjuvant Radiotherapy with Tomo-Helical and Tomo-Direct Treatment Techniques in Breast Cancer. Accuray User Meeting, Nisan 2016, San Francisco, USA

B25. Taşçı N, Yeşil A, Yılmaz İ, Yılmaz F, Meral Ö, Özcan D, Topkan E, Pehlivan B. The Investigation of Treatment Accuracy for Breast Cancer Radiotherapy Based on Daily Imaging. Accuray User Meeting, Nisan 2016, San Francisco, USA

B26. Taşçı N, Yeşil A, Yılmaz I, Çil A, Meral Ö, Özcan D, Pehlivan B. Adaptive Managemet Plans and Investigation of Accuracy of Lung Radiosurgery. Accuray User Meeting, Nisan 2016, San Francisco, USA

C. Articles published in national peer-reviewed journals:

C1. Pehlivan B, Topkan E, Yavuz A.: Protonterapy in clinical use. Ege Tıp Dergisi, 50(1):1-6, 2011

D. The papers presented at national scientific meetings and published in the proceedings book:

D1. Pehlivan B, Zorlu F, Yıldız F, Gürkaynak M, Akyol F, Kars A, Atahan IL.: Preoperatif radyoterapi alan rektum kanserli hastalarda sonuçlarımız. Ulusal Kanser Kongresi, Nisan 2004, Antalya.

D2. Pehlivan B, Zorlu F, Cengiz M, Akyol F, Gürkaynak M, Altundağ K, Tekuzman G, Atahan LI.: Opere mide kanserli hastalarda adjuvan radyoterapi sonuçları ve prognostik faktör analizi. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2004, Antalya.

D3. Dhermain F, Pehlivan B, Ducreux D, Beaudre A, Bidault F, Parker F, Haie-Meder C, Lefkopoulos D, Bourhis J.: Grad 2 ve Grad 3 oligodendriogliomlu hastaların radyoterapi planlamasında fonksiyonel magnetik resonansın yeri:ilk 10 hastanın sonuçları. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2006, Antalya.

D4. Yavuz MN, Pehlivan B, Aydın M, Topkan E, Önal C, Reyhan M, Kötek A, Yapar AF, Yavuz AA.: Rektum kanserinin preoperatif radyoterapisinde BT ile PET-BT bazlı 3-boyutlu konformal radyoterapi planlarının karşılaştırılması. XVIII. Ulusal Kanser Kongresi, Nisan 2009, Antalya.

D5. Pehlivan B,Yavuz M, Topuk S, Topkan E, Yavuz A.: Servikal vertebra agresif osteoblastomlu hastada 18- FDG-PET-BT bazlı küratif radyoterapi: olgu sunumu. Ulusal Kanser Kongresi, Nisan 2009, Antalya.

D6. Sönmez A,Pehlivan B, Arslan G, Yavuz A, Topkan E, Sönmez S, Yavuz M.: Tüm vücut ışınlamasında multi leaf kolimatör ile ikincil alt alan tekniği. Ulusal Kanser Kongresi, Nisan 2009, Antalya.

D7. Önal C, Oymak E, Arslan G, Pehlivan B, Topkan E, Yavuz MN, Yavuz AA.: İntrakaviter brakiterapi uygulanan serviks kanserli hastalarda konvansiyonel plan ile 3 boyutlu planın karşılaştırılması. XVIII. Ulusal Kanser Kongresi, Nisan 2009, Antalya.

D8. Önal C, Kayaselçuk F, Erdem R, Oymak E, Pehlivan B, Topkan E, Yavuz M, Bacanlı D, Yavuz A.: Radyasyon enteritinin önlenmesinde melatonin ve oktreotidin etkinliklerinin karşılaştırılması. XVIII. Ulusal Kanser Kongresi, Nisan 2009, Antalya.

D9. Pehlivan B, Ares C, Stadelmann O, Lomax A, Goitein G, Timmermann B, Schneider R, Hug EB. Protonterapi uygulanan kafa tabanı kordoma ve kondrosarkomalarında temporal lob toksisitesi analizi. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D10. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. PET-BT bazlı radyoterapi planlaması sonrası elektif nodal ışınlama yapılmaksızın tedavi edilen lokal ileri evre pankreas kanserinde sağkalım sonuçları. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D11. Pehlivan B. Kötek A, Akkaneren Ş, Topkan E. Lokal ileri evre küçük hücreli dışı akciğer kanseri tanısı nedeniyle ardışık veya eşzamanlı kemoradyoterapi uygulanan hastalarda profilaktik kranyal ışınlama. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D12. Pehlivan B, Yuksel O, Akkaneren Ş, Topkan E. Radyoterapi ve eş zamanlı temozolomid ile tedavi edilen glioblastoma multiforme hastalarında psödoprogresyon. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D13. Pehlivan B. Kötek A, Akkaneren Ş, Topkan E. Karaciğer metastazları tanılı hastalarda BT ve PET/BT füzyonu bazlı radyoterapi planlarının karşılaştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D14. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. FDG-PET/BT bazlı üç boyutlu konformal radyoterapi planı ile tedavi edilen karaciğer metastazlarında lokal kontrol ve sağkalım sonuçları. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D15. Pehlivan B, Kötek A, Akkaneren Ş, Topkan E. Profilaktik oral glutamin kullanımının eş zamanlı pelvik radyokemoterapiye bağlı akut diareyi önlemedeki etkisinin retrospektif olarak değerlendirilmesi. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D16. Pehlivan B, Oymak E, Akkaneren Ş, Kötek A, Topkan E. Profilaktik oral glutamine kullanımının torasik radyoterapi ile tedavi edilen küçük hücre dışı akciğer kanserlerinde radyoterapiye sağkalım üzerine etkisi. Ulusal Radyasyon Onkolojisi Kongresi Nisan 2010, Girne.

D17. Pehlivan B, Yavuz MN, Bal N, Topkan C, Önal C, Yavuz AA. Radyoterapinin testiste oluşturduğu hasarın önlenmesinde amifostin, melatonin ve 5-androstenediol’un radyoprotektif etkinliklerinin karşılaştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D18. Kötek A, Pehlivan B, Acıbucu İ, Dölek Y, Yavuz AA, Yavuz E, Topkan E. Meme Koruyucu cerrahi veya modifiye radikal mastektomi sonrası 4 farklı teknikle 3 boyutlu konformal radyoterapi uygulanan hastalardaki karşı meme dozu. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D19. Eren Ş, Yüksel Ö, Kötek A, Oymak E, Topuk S, Pehlivan B, Önal C, Topkan E. “Servikal kanser tanılı ve brakiterapi uygulanamayan hastalarda üç boyutlu konformal boost tedavisi sonuçları. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2010, Girne.

D20. Şengül K, Toksoy T, Özturk O, Öztürk H, Parlak C, Topkan E, Pehlivan B: Maliğn Mezotelyoma Tedavisinde Helikal Tomoterapi ve Rapid Ark Tedavi Tekniklerinin Dozimetrik Olarak Karşılaştırılması. 11. Ulusal Radyasyon Onkolojisi Kongresi,  Nisan 2014, Antalya.

D21. Şengül K, Toksoy T, Özturk O, Pehlivan B. Baş Boyun Kanserli Hastalarda 3 Farklı Radyoterapi Tekniğinin Karşılaştırılması. 11. Ulusal Radyasyon Onkolojisi Kongresi,  Nisan 2014, Antalya.

D22. Pehlivan B, Herrera F, Bouchaab H, Vallet V, Pasche P, Simon C, Bourhis J, Özşahin M. Nüks Baş Boyun Kanserli Hastalarda Postoperaif HDR Brakiterapi Sonuçları. 11. Ulusal Radyasyon Onkolojisi Kongresi,  Nisan 2014, Antalya.

D23. Özturk O, Şengül K, Yılmaz G, Ozsahin M, Pehlivan B. Prostat Kanseri Tedavisinde Volümetrik Ayarlı Ark Tedavisi ve Yoğunluk Ayarlı Radyoterapinin Karşılaştırılması. 11. Ulusal Radyasyon Onkolojisi Kongresi,  Nisan 2014, Antalya.

D24. Yeşil A, Taşçı N, Özcan D, Bayazıt B, Çil A, Pehlivan B. Total Vücut Işınlamalarında Tomo-Helikal ve Tomo-Direk Tedavi Tekniklerinin Karşılaştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2016, Antalya

D25. Özcan D, Yeşil A, Taşçı N, Yılmaz F, Meral Ö, Pehlivan B, Topkan E. “Simultaneous Integrated Boost” (SIB) Tekniğiyle Skalp ve Hipokampüs Koruyucu Tüm Beyin Işınlaması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2016, Antalya

D26. Taşçı N, Yeşil A, Yılmaz İ, Meral Ö, Özcan D, Pehlivan B. Akciğer SBRT Planlarının, Tedavi Öncesi ve Sonrası Alınan Görüntülerle Elde Edilen Adaptif Planlar ile Karşılaştırılarak Tedavi Doğruluğunun Araştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2016, Antalya

D27. Taşçı N, Yılmaz İ, Yeşil A,  Yılmaz F, Meral Ö, Özcan D, Pehlivan B. Meme Kanserli Hastaların Radyoterapisinde Tedavi Doğruluğunun Her Tedavi Öncesi Alınan MVCT Görüntüleriyle Oluşturulan Adaptif Planlar Yardımıyla Araştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2016, Antalya

D28. Yeşil A, Taşçı N, Yılmaz F, Özcan D, Pehlivan B. Farklı Çaptaki Hedef Volümlere Yapılan Planlar ile Tomoterapinin Radyocerrahideki Etkinliğinin Araştırılması. Ulusal Radyasyon Onkolojisi Kongresi, Nisan 2016, Antalya

Back to top button